Prism AI Therapeutics

Prism AI Therapeutics provides an AI-first multi-omics management platform that uniquely enables biotech companies and health systems to unlock the value of real-world multi-omic data and develop the next generation of drugs and biomarkers. The platform is powered by proprietary quantum mechanics-based AI/ML, and is supported by end-to-end global biospecimen sourcing and molecular profiling services. We and our partners have experimentally validated that our AI/ML is uniquely able to make accurate, precise, clinically actionable, and mechanistically interpretable discoveries from real-world multi-omic data. We excel in (i) discovering biomarkers of response and survival, disease models, and drug targets that consistently validate across studies and over time in federated, small-cohort, noisy, and high-dimensional data, (ii) integrating multi-omic data for discovery and validation of multi-modal predictors, (iii) separating the predictors from normal demographic variations, and (iv) removing systematic batch effects from the data. Let’s join forces to conquer disease.